De nya importtullar som USA har aviserat orsakar huvudbry för flera bolag på Helsingforsbörsen, förutom att de generellt försvagar de globala ekonomiska utsikterna och ökar osäkerheten.

As expected, the FDA cleared Revenio's new iCare MAIA microperimeter. Thus, the new iCare MAIA microperimeter is now available for sale in the US, with deliveries starting in mid-April 2025, according to the company.

Under the iCare brand, Revenio offers excellent tonometers, fundus imaging devices and perimeters. The next step in the company's evolution is to move from being an equipment supplier to providing complete ophthalmic diagnostic solutions, where software and a proprietary AI algorithm are critical.